$27.000
+0.011 (+0.04%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
KALV-Prognose durch Analyse ähnlicher Charts
Alphio's KALV stock price prediction model matches the current Kalvista Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.06 (+0.22%). The 1-week path is $27.09 (+0.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Kalvista Pharmaceuticals Inc-Aktien kaufen?
KalVista Pharmaceuticals is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 to deploy. The stock is already trading right around the deal price of $27 in pre-market, which limits upside from here. Because the company has been acquired for $27 per share in cash, the trade is now mainly a merger-arbitrage setup rather than a normal long-term investment. Since the user is impatient and does not want to wait for a better entry, the direct answer is to hold rather than buy aggressively at this level.
KALV schloss am Wednesday bei $27.00, nachdem der Kurs +0.04% gestiegen ist
Kalvista Pharmaceuticals Inc (KALV) last closed at $27, gaining +0.04%. These facts feed the 1-day and 1-week KALV price prediction above.
Analystenkonsens
Kalvista Pharmaceuticals Inc (KALV): 1 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Kalvista Pharmaceuticals Inc (KALV) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf KALV am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für KALV
Historically the probability of a positive August return for KALV is 97.67%. August offers the highest probability of a positive month at 97.67%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.